- Estimated worth: $0
- Daily visitors: 0
- Global rank: #more than 1,000,000 out of 1,000,000 tracked websites
- Daily revenue: $0
- Domain age: 2001-11-26 17:57:49
- SSL: Not detected
- Hosted in: Germany
Source: Statvoo analysis of embl-ventures.com, updated Jul 2026. Methodology
embl-ventures.com does not currently appear in the top 1 million websites by traffic. Limited data is available, but the domain has an estimated value of $0 based on available signals.
The site runs on a .com (commercial) domain with servers located in Germany, primary IP address 81.89.192.67. Its homepage is titled βEMBL Ventures - we invest in life science companiesβ.
embl-ventures.com was first registered on 2001-11-26 through InterNetX GmbH.
Users commonly reach embl-ventures.com by searching for "embl ventures", "embl ventures gmbh", "greenfield venture meaning", "define venture creation", "venture or ventures".
People searching for these terms often visit embl-ventures.com:
embl venturesembl ventures gmbhgreenfield venture meaningdefine venture creationventure or ventures| SSL Certificate | Not Detected |
| Security Score | 0% |
| Strict-Transport-Security | β |
| Content-Security-Policy | β |
| X-Content-Type-Options | β |
| X-Frame-Options | β |
| X-XSS-Protection | β |
Based on our analysis, embl-ventures.com does not appear to use HTTPS and scores 0% on security headers. There is room for improvement in security configuration.
embl-ventures.com is missing 5 of 5 recommended security headers (Strict-Transport-Security, Content-Security-Policy, X-Content-Type-Options, X-Frame-Options, X-XSS-Protection). This leaves visitors more exposed to browser-based attacks.
| Purchase/Sale Value | $0 |
| Daily Revenue | $0 |
| Monthly Revenue | $0 |
| Yearly Revenue | $0 |
| Daily Visitors | 0 |
All values are estimates based on publicly available traffic data.
| Website | embl-ventures.com |
| Domain Age | 2001-11-26 17:57:49 |
| TLD | .com |
| Hosting Location | Germany |
| Primary IP | 81.89.192.67 |
Hosted in Germany, a major European data center hub. This provides fast access for EU users and compliance with European data regulations.
Registered in 2001, embl-ventures.com is a veteran domain at 24+ years old. Long-established domains carry more trust with users and search engines.
These technologies were detected from embl-ventures.com's HTTP response headers.
| Host | Type | IP | Nameserver |
|---|---|---|---|
| embl-ventures.com | A | 81.89.192.67 | ns1.hd-it.eu. |
| embl-ventures.com | A | 5.45.111.167 | ns3.hd-it.eu. |
| embl-ventures.com | A | 217.69.239.12 | ns2.hd-it.eu. |
Date
Server
Link
Keep-Alive
Connection
Content-Type
| Registrar | InterNetX GmbH |
| Registered | 2001-11-26 17:57:49 |
| Status | Active |
Registered in 2001, embl-ventures.com is a veteran domain at 24+ years old. Long-established domains carry more trust with users and search engines.
Full WHOIS record βHow much is embl-ventures.com worth?
embl-ventures.com has an estimated value of $0 based on its traffic volume, global ranking, and projected advertising revenue.
How much traffic does embl-ventures.com get?
embl-ventures.com receives approximately 0 unique visitors per day. Its global traffic rank is #more than 1,000,000.
Is embl-ventures.com safe to visit?
embl-ventures.com does not appear to have HTTPS enabled, which may be a concern. Always exercise caution when entering personal information on any website.
Where is embl-ventures.com hosted?
The servers for embl-ventures.com are located in Germany.
Who owns embl-ventures.com?
Ownership details for embl-ventures.com can be found in the WHOIS section below. Many domain owners use privacy protection services to keep their registration details private.
| Domain | embl-ventures.com |
| TLD | .com |
| SSL | Not Detected |
| Server Location | Germany |
| Global Rank | #more than 1,000,000 |
| Registrar | InterNetX GmbH |
| Domain Age | 2001-11-26 17:57:49 |
| Title | EMBL Ventures - we invest in life science companies |
| Description | EMBL Ventures invest throughout Europe with the aim to build companies that create significant commercial opportunities based on new therapeutic treatment. |